Table 1.

Baseline Demographics of Table 1. Patients treated across the SPOTRIAS consortium between January 1^st 2005 and December 31^st 2010

	All Treated Patients^*		Intravenous recombinant tissue plasminogen activator^#		Any Intra- arterial Therapy		Bridging Therapy^&		Endovascular Therapy Alone^{^}
	n =	%	n =	%	n =	%	n =	%	n =	%
Proportion over age 80	1182	31.4	1095	32.4	186	23	102	24	84	21.9
Sex (% female)	1859	49.4	1699	50.4	419	52.1	219	51.8	200	52.4
Race/ethnicity
Hispanic	379	10.1	344	10.2	64	7.9	29	6.8	35	9.1
Non-Hispanic	688	18.3	612	18.1	144	17.8	71	16.7	73	19.1
Non-Hispanic white	2530	67.1	2269	67.2	559	69.2	301	70.8	258	67.4
Other	171	4.5	153	4.5	41	5.1	24	5.6	17	4.4
Deaths	431	12.1	359	12.2	145	18.5	76	18.3	69	18.8
Disposition (Not discharged home)	2412	64	2119	62.7	628	77.7	340	80	288	75.2

NIHSS, median (IQR): 12 (6–18)

NIHSS, median (IQR): 16 (11–20)

NIHSS, median (IQR): 17 (13–20.5)

^{^}

NIHSS, median (IQR): 15 (8–20)